SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 38 filers reported holding SPRING BK PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARSONS CAPITAL MANAGEMENT INC/RI | 195,165 | $1,559,000 | 0.21% |
| DAFNA Capital Management LLC | 27,412 | $219,000 | 0.19% |
| Verity & Verity, LLC | 12,385 | $99,000 | 0.03% |
| Baker Brothers Advisors | 219,298 | $1,752,000 | 0.02% |
| Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
| Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 97,286 | $777,000 | 0.01% |
| BRYN MAWR TRUST Co | 14,000 | $112,000 | 0.01% |
| BlackRock Investment Management, LLC | 163 | $1,000 | 0.00% |
| MORGAN STANLEY | 12,500 | $100,000 | 0.00% |